News‎ > ‎

News Items


21/03/2019 - AI3SD Publishes Paper in Expert Opinion in Drug Discovery

posted 21 Mar 2019, 12:34 by Samantha Kanza   [ updated 21 Mar 2019, 12:34 ]

Dr Samantha Kanza & Professor Jeremy Frey had an article accepted into Expert Opinion in Drug Discovery entitled: "A new wave of innovation in Semantic Web Tools for Drug Discovery:.

21/03/2019 - Announcing our successful Funding Applicants for AI3SD-FundingCall1

posted 21 Mar 2019, 11:40 by Samantha Kanza   [ updated 1 Apr 2019, 03:57 ]

In our first funding call AI3SD-FundingCall1, 3 successful projects have now been selected for funding (pending contract negotiations): 
  • Project Title: Predicting the Activity of Drug Candidates where there is No Target 
    Principal Investigator: Professor Matthew Todd
    Lead Institution: UCL
    Project Partners: Auromind, ExScientia & Intellegens

  • Project Title: 'Next-next' Generation Quantum DNA Sequencing with Chemical Surface Design and Capsule Nets 
    Principal Investigator: Professor Tim Albrecht
    Lead Institution: University of Birmingham
    Project Partner: City, University of London
     
  • Project Title: Deep Learning enhanced quantum chemistry: Pushing the limits of Materials Discovery
    Principal Investigator: Dr Reinhard J. Maurer
    Lead Institution: University of Warwick
    Project Partners: University of Strathclyde & Carnegie Mellon University

20/03/2019 - 2nd AI3SD Advisory Board Meeting

posted 21 Mar 2019, 09:27 by Samantha Kanza   [ updated 1 Apr 2019, 06:53 by Nicola Knight ]

On Wednesday 20th March we held our second Advisory Board Meeting. This was a very useful meeting, whereby we updated the Advisory board of the progress of the Network+ and sought their advice regarding the funding applications. The Advisory Board and Network Team discussed the plans for the rest of 2019 and started making plans for 2020 with respect to the activities the Network+ should be focusing on. The Network+ Advisory Board is chaired by Professor John Overington of the Medicines Catapult and is currently comprised of 13 highly experienced individuals from both industry and academia, with a wide range of relevant skills to our Network+. The purpose of the Network+ Advisory Board (AB) is to provide advice on the conduct and content of the AI3SD Network+. This encompasses helping to identify major streams of research for the network and to both commission and assess research proposals. Details on the Advisory Board members can be found on our Advisory Board Page.

03/10/2018 - 1st AI3SD Advisory Board Meeting

posted 30 Oct 2018, 04:45 by Samantha Kanza   [ updated 1 Apr 2019, 06:54 by Nicola Knight ]

On Wednesday 3rd October we held our first Advisory Board Meeting. This was a very useful first meeting where we discussed the main aims and activities of the Network+, agreed upon the role of the Advisory Board, and started planning the Network+ events and funding calls for 2019 with a careful consideration of how to best align these to the Network+ aims.  The Network+ Advisory Board is chaired by Professor John Overington of the Medicines Catapult and is currently comprised of 13 highly experienced individuals from both industry and academia, with a wide range of relevant skills to our Network+. The purpose of the Network+ Advisory Board (AB) is to provide advice on the conduct and content of the AI3SD Network+. This encompasses helping to identify major streams of research for the network and to both commission and assess research proposals. Details on the Advisory Board members can be found on our Advisory Board Page.

01/08/2018 - Social Media & Contacts

posted 27 Sep 2018, 08:38 by Samantha Kanza   [ updated 30 Oct 2018, 04:48 ]

If you want to keep up to date with all of our news, then follow us on twitter at @AISciNet! 
If you have any questions please don't hesitate to email us on info@ai3sd.org

1-5 of 5